Cargando…
An Overview of Repurposed Drugs for Potential COVID-19 Treatment
The COVID-19 pandemic caused by SARS-CoV-2 has placed severe constraints on healthcare systems around the globe. The SARS-CoV-2 virus has caused upheaval in the healthcare and economic sectors worldwide. On the 20th of May 2020, the World Health Organisation declared COVID-19 a global pandemic due t...
Autores principales: | Govender, Kamini, Chuturgoon, Anil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774286/ https://www.ncbi.nlm.nih.gov/pubmed/36551336 http://dx.doi.org/10.3390/antibiotics11121678 |
Ejemplares similares
-
Drug repurposing for the treatment of COVID-19
por: Kato, Yuri, et al.
Publicado: (2022) -
Drug Repurposing Approach, Potential Drugs, and Novel Drug Targets for COVID-19 Treatment
por: Kifle, Zemene Demelash, et al.
Publicado: (2021) -
The Potential of Nanobodies for COVID-19 Diagnostics and Therapeutics
por: Naidoo, Dhaneshree Bestinee, et al.
Publicado: (2023) -
Repurposing Existing Drugs for the Treatment of COVID-19
por: Farne, Hugo, et al.
Publicado: (2020) -
Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview
por: Al-Karmalawy, Ahmed A., et al.
Publicado: (2021)